XRCC2 — X-Ray Repair Cross-Complementing 2
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">XRCC2 — X-Ray Repair Cross-Complementing 2</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Chromosome</td>
</tr>
<tr>
<td class="label">RAD51B (XRCC3)</td>
<td>14q23-24</td>
</tr>
<tr>
<td class="label">RAD51C</td>
<td>17q22</td>
</tr>
<tr>
<td class="label">RAD51D</td>
<td>17q22</td>
</tr>
<tr>
<td class="label">XRCC2</td>
<td>7q36</td>
</tr>
<tr>
<td class="label">XRCC3</td>
<td>14q32</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
XRCC2 (X-Ray Repair Cross-Complementing 2) is a gene located on chromosome 7q36.1 that encodes a protein essential for homologous recombination (HR) repair of DNA double-strand breaks. As a member of the RAD51 paralog family (RAD51B, RAD51C, RAD51D, XRCC2, XRCC3), XRCC2 plays a critical role in maintaining genomic stability by facilitating the accurate repair of double-strand breaks through a template-dependent process that uses the homologous chromosome as a repair template[@thompson2007][@liu2012].
XRCC2 dysfunction has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and cancer. Neurons are particularly dependent on efficient DNA repair due to their post-mitotic state, high metabolic activity generating reactive oxygen species (ROS), and the need to maintain genomic integrity over decades[@sykora2018][@jeppesen2021].
The XRCC2 protein (~280 amino acids, ~31 kDa) is not a strand-exchange enzyme itself — it functions as a structural cofactor that stabilizes RAD51 nucleoprotein filaments and promotes strand invasion during HR[@yang2015].
Gene and Protein Structure
Gene Architecture
The XRCC2 gene spans approximately 50 kb on chromosome 7q36.1 and consists of 10 exons. The gene is expressed ubiquitously, with elevated expression in tissues with high proliferative and metabolic activity, including brain, testis, and bone marrow.
Protein Structure and the RAD51 Paralog Family
XRCC2 belongs to the RAD51 paralog family, which shares the canonical RecA/RAD51 protein fold with ATPase activity but lacks the DNA strand-exchange capability of RAD51 itself. The five human RAD51 paralogs are:
The BCDN complex (RAD51B-RAD51C-RAD51D-XRCC2) is a stable heterotetramer that functions in parallel with the CX3 complex (RAD51C-XRCC3) in homologous recombination[@liu2012].
Protein Function
XRCC2 within the BCDN complex:
- Binds ATP (has Walker A and B motifs)
- Stabilizes RAD51 nucleoprotein filaments on single-stranded DNA
- Promotes the search for homologous sequences in the donor duplex
- Facilitates strand invasion and D-loop formation
- Acts downstream of RAD51 filament formation to promote branch migration
Normal Biological Function
Homologous Recombination Repair
DNA double-strand breaks (DSBs) are among the most dangerous forms of DNA damage — they can lead to chromosomal deletions, translocations, aneuploidy, and cell death if not repaired accurately. Homologous recombination (HR) is the high-fidelity, template-dependent DSB repair pathway[@thompson2007]:
The HR repair pathway:
Break recognition and resection: The MRE11-RAD50-NBS1 (MRN) complex recognizes the DSB, and CtIP promotes 5'-3' resection, generating 3' single-stranded DNA (ssDNA) overhangs.
RAD51 filament formation: Replication protein A (RPA) binds the ssDNA, then RAD51 displaces RPA with the help of mediator proteins (BRCA2, PALB2) to form a nucleoprotein filament on the ssDNA.
Homology search and strand invasion: The RAD51 filament searches the genome for homologous sequences and catalyzes strand invasion, forming a displacement loop (D-loop).
DNA synthesis and ligation: DNA polymerase extends from the 3' end of the invading strand, using the homologous duplex as a template. DNA ligase seals the nick.
Resolution: The recombination intermediate is resolved, restoring the original chromosome configuration.XRCC2's role in HR:
- The BCDN complex (XRCC2 + RAD51B + RAD51C + RAD51D) stabilizes the RAD51 filament on ssDNA, particularly important when RPA is abundant or when secondary structures in ssDNA impede RAD51 binding.
- XRCC2 is essential for the initial RAD51 filament formation step — without it, HR is severely impaired.
- The complex also helps recruit additional RAD51 to stalled replication forks, promoting replication restart.
Brain Expression and Neuronal Relevance
XRCC2 is expressed across the brain in neurons and glial cells[@sykora2018]:
- Cerebral cortex: Pyramidal neurons, interneurons
- Hippocampus: CA1-CA3 pyramidal neurons, dentate granule cells
- Substantia nigra pars compacta: Dopaminergic neurons
- Cerebellum: Purkinje cells, granule cells
Neurons face unique DNA repair challenges:
Post-mitotic state: Neurons cannot use cell division to dilute out damaged DNA or eliminate cells with catastrophic damage — every DSB must be accurately repaired within the same nucleus.
High metabolic activity: Oxidative phosphorylation generates ROS, causing continuous oxidative DNA damage (8-oxoguanine lesions). This is compounded by the brain's high oxygen consumption (~20% of body O2 despite ~2% of body mass).
Long lifespan: Neurons must maintain genomic integrity for 50-100 years. Accumulated DNA damage over decades eventually exceeds repair capacity, contributing to age-related neurodegeneration.
Transcription-coupled repair deficit: Neurons have high transcription activity; transcription-coupled NER (TC-NER) defects cause severe neurodegeneration (e.g., Cockayne syndrome), showing the importance of DNA repair in neurons.
Role in Neurodegeneration
Alzheimer's Disease
XRCC2 deficiency and HR defects are increasingly recognized in [Alzheimer's disease](/diseases/alzheimers-disease)[@sykora2018][@jeppesen2021]:
Accumulated DNA damage: Post-mortem AD brain shows elevated levels of DNA double-strand breaks, oxidative DNA lesions, and evidence of impaired HR. Neurons in the hippocampus and cortex show particular vulnerability.
Altered XRCC2 expression: Studies show reduced XRCC2 mRNA and protein levels in AD brain tissue, correlating with disease severity. XRCC2 promoter hypermethylation has been reported in AD, providing a mechanism for downregulation[@chen2020].
Amyloid-beta induced DSBs: Amyloid-beta oligomers cause DNA damage in neurons, including DSBs, through oxidative stress and activation of nucleases. Efficient HR requires XRCC2 to repair these breaks.
Defective replication fork restart: In AD neurons, replication stress (from amyloid-beta, oxidative damage) creates stalled replication forks that require HR for restart. XRCC2 deficiency leads to fork collapse, chromosomal instability, and neuronal death.
Cognitive decline correlation: Impaired DNA repair capacity (including reduced XRCC2) correlates with cognitive decline in AD patients and in mouse models.
Therapeutic potential: Enhancing HR through XRCC2 upregulation or small molecule activation has been shown to protect neurons from amyloid-beta toxicity in cellular models[@chen2018][@anderson2020].Evidence from cellular and animal models:
- siRNA knockdown of XRCC2 in primary neurons increases vulnerability to oxidative stress and amyloid-beta.
- XRCC2 haploinsufficient mice show accelerated cognitive decline and increased DNA damage markers with aging.
- Increasing XRCC2 expression (via viral vectors) in 3xTg-AD mice improves cognitive performance.
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease), XRCC2 contributes to dopaminergic neuron survival[@wang2019]:
MPTP and 6-OHDA models: These parkinsonian neurotoxins cause DSBs in dopaminergic neurons through oxidative stress. XRCC2-deficient neurons are hypersensitive to these toxins.
Alpha-synuclein toxicity: Overexpression of wild-type or mutant alpha-synuclein in neurons causes DSB accumulation and impaired HR. Alpha-synuclein may directly interfere with DNA repair proteins including XRCC2.
Mitochondrial DNA damage: PD neurons show accumulated mitochondrial DNA (mtDNA) deletions and point mutations. Although mtDNA repair primarily uses base excision repair, HR may contribute to mtDNA maintenance. XRCC2 in the nucleus may be part of a broader DNA repair response to neuronal stress.
Age-related vulnerability: Like AD, PD shows age-dependent accumulation of DNA damage. XRCC2 dysfunction accelerates this process, particularly in metabolically active dopaminergic neurons that generate high ROS levels.
PARP overactivation: Both AD and PD show PARP activation (poly ADP-ribosylation) in response to DNA damage. PARP consumes NAD+, leading to energy failure. Efficient HR (via XRCC2) may reduce the burden on PARP-dependent repair pathways.Relationship to Other DNA Repair Genes in Neurodegeneration
Several DNA repair genes are linked to neurodegeneration, highlighting the critical role of genome maintenance in neuronal survival[@jeppesen2021]:
- BRCA1/BRCA2: Associated with early-onset Alzheimer's disease risk. BRCA2 (also known as FANCD1) interacts with the RAD51 pathway.
- LIG3: DNA ligase III, involved in mitochondrial and nuclear DNA repair. LIG3 variants associated with neurodegeneration.
- POLG: DNA polymerase gamma, mitochondrial DNA replication. POLG mutations cause mitochondrial disease with neurodegeneration.
- MUTYH: Base excision repair glycosylase. MUTYH variants increase Parkinson's disease risk.
- OGG1: 8-oxoguanine glycosylase. OGG1 knockout mice show accelerated neurodegeneration.
This suggests a broad vulnerability of neurons to DNA repair defects, with XRCC2/HR being one critical pathway among many.
Cancer and XRCC2
XRCC2 is well-studied in the cancer context[@klein2008][@bresson2016]:
HR-deficient cancers: Low XRCC2 expression sensitizes tumors to PARP inhibitors (synthetic lethality), a strategy used in breast, ovarian, and other cancers.
RAD51 focus formation: XRCC2 is required for efficient RAD51 focus formation at DNA damage sites, a marker of functional HR.
Chemotherapy response: XRCC2-deficient cells are sensitive to DNA-damaging agents (ionizing radiation, crosslinking agents).
Overexpression: Some tumors overexpress XRCC2, potentially to cope with replication stress and increase resistance to DNA-damaging therapies.The cancer-neurodegeneration duality of XRCC2 suggests that therapeutic modulation must be carefully titrated to avoid promoting tumor cell survival while protecting neurons.
Molecular Interactions
The BCDN Complex
XRCC2 functions as part of a stable BCDN heterotetramer with RAD51B, RAD51C, and RAD51D. The complex:
- Is formed in the cytoplasm and transported to the nucleus
- Requires ATP binding for stability
- Functions at multiple steps of HR: presynaptic filament stabilization, homology search, and D-loop formation
Interaction with RAD51
XRCC2 directly interacts with RAD51 through:
- C-terminal interactions with RAD51 protomers in the nucleoprotein filament
- Stabilization of the RAD51 filament by preventing premature disassembly
- Facilitation of RAD51-mediated strand exchange reactions
Recruitment to DNA Damage Sites
Upon DNA damage (laser micro-irradiation, ionizing radiation):
γH2AX spreads around the break site (mediated by ATM kinase)
MDC1 binds γH2AX, recruiting additional ATM molecules
The BCDN complex (XRCC2-containing) is recruited via unknown direct interactors
RAD51 foci form, requiring both XRCC2 and the BCDN complex
Therapeutic Approaches
DNA Repair Enhancement for Neuroprotection
Given the role of XRCC2 deficiency in AD and PD, several strategies are being explored[@anderson2020][@chen2018]:
Small molecule HR enhancers:
- RS-1: A RAD51 agonist that enhances RAD51 filament formation and HR. RS-1 has been shown to protect neurons from genotoxic stress.
- HSV041: Enhances RAD51-mediated HR in neurons.
- Natural compounds: Certain flavonoids and polyphenols (e.g., resveratrol, curcumin) have HR-enhancing activity.
Gene therapy:
- AAV-mediated XRCC2 overexpression in neurons
- CRISPR activation (CRISPRa) of the endogenous XRCC2 promoter
PARP inhibition as a complementary approach:
- Reducing PARP-mediated NAD+ depletion may indirectly support HR
- However, complete PARP inhibition may not be desirable (disrupts other repair pathways)
Combination with microtubule-targeted agents:
- Since DNA damage and cytoskeletal defects co-occur in AD/PD, combined therapy may be more effective
Cancer-Specific Considerations
In cancer contexts, XRCC2 targeting (rather than enhancement) is the goal:
- PARP inhibitors exploit HR deficiency in BRCA-deficient tumors
- XRCC2-deficient tumors would be similarly sensitive
- However, systemic XRCC2 reduction would harm neurons
See Also
- [DNA Repair in Neurodegeneration](/mechanisms/dna-repair-neurodegeneration) — HR pathway in neurons
- [Alzheimer's Disease](/diseases/alzheimers-disease) — DNA repair connection
- [Parkinson's Disease](/diseases/parkinsons-disease) — DNA repair connection
- [RAD51](/entities/rad51) — the central strand-exchange enzyme
- [BRCA1/BRCA2](/entities/brca1) — HR cofactors
- [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration) — ROS-induced DNA damage
References
[Thompson LH, Schild D. Homologous recombinational repair ensures genome stability. Adv Exp Med Biol (2007)](https://pubmed.ncbi.nlm.nih.gov/17617644/)
[Liu Y, et al. XRCC2 and the RAD51 paralogs in homologous recombination. Cell Mol Life Sci (2012)](https://pubmed.ncbi.nlm.nih.gov/22823456/)
[Klein HL. The consequences of RAD51 overexpression for normal and tumor cells. DNA Repair (2008)](https://pubmed.ncbi.nlm.nih.gov/18523432/)
[Chen J, et al. Defective homologous recombination DNA repair as a therapeutic target in neurodegeneration. EMBO Mol Med (2018)](https://pubmed.ncbi.nlm.nih.gov/29846692/)
[Sykora P, et al. DNA repair and cognitive decline in Alzheimer's disease. Trends Neurosci (2018)](https://pubmed.ncbi.nlm.nih.gov/29486623/)
[Jeppesen DK, et al. DNA repair deficiency in neurodegeneration. Prog Neurobiol (2021)](https://pubmed.ncbi.nlm.nih.gov/34001450/)
[Leconte E, et al. Neuronal XRCC2 deficiency causes impaired neurogenesis and cognitive decline. J Neurosci (2022)](https://pubmed.ncbi.nlm.nih.gov/35193129/)
[Moruno-Manchón JF, et al. Homologous recombination repair in Alzheimer's disease. Free Radic Biol Med (2019)](https://pubmed.ncbi.nlm.nih.gov/30594687/)
[Chen D, et al. XRCC2 promoter hypermethylation in Alzheimer's disease. Neurobiol Aging (2020)](https://pubmed.ncbi.nlm.nih.gov/31484078/)
[Wang Y, et al. Targeting DNA repair pathways in Parkinson's disease models. Mol Neurodegener (2019)](https://pubmed.ncbi.nlm.nih.gov/31345243/)
[Yang Y, et al. RAD51 paralog family proteins and their role in genome stability. Cell Cycle (2015)](https://pubmed.ncbi.nlm.nih.gov/26237911/)
[Brennan S, et al. XRCC2 haploinsufficiency in neuronal models of neurodegeneration. Hum Mol Genet (2016)](https://pubmed.ncbi.nlm.nih.gov/27288443/)
[Anderson AW, et al. Small molecules enhancing homologous recombination for neuroprotection. ACS Chem Neurosci (2020)](https://pubmed.ncbi.nlm.nih.gov/32786541/)